929 results on '"Pozzi, C"'
Search Results
2. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy
- Author
-
Coppo, R., Feehaly, J., Troyanov, S., Cattran, D.C., Cook, H.T., Roberts, I., Radcliffe, John, Russo, M.L., Tesar, V., Maixnerova, D., Lundberg, S., Gesualdo, L., Emma, F., Fuiano, L., Beltrame, G., Rollino, C., Amore, A., Camilla, R., Peruzzi, L., Praga, M., Feriozzi, S., Polci, R., Segoloni, G., Colla, L., Pani, A., Piras, D., Angioi, A., Cancarini, G., Ravera, S., Durlik, M., Moggia, E., Ballarin, J., Di Giulio, S., Pugliese, F., Serriello, I., Caliskan, Y., Sever, M., Kilicaslan, I., Locatelli, F., Del Vecchio, L., Wetzels, J.F.M., Peters, H., Berg, U., Carvalho, F., da Costa Ferreira, A.C., Maggio, M., Wiecek, A., Ots-Rosenberg, M., Magistroni, R., Topaloglu, R., Bilginer, Y., D’Amico, M., Papagianni, K., Stangou, M., Giacchino, F., Goumenos, D., Papasotirious, M., Kalliakmani, P., Gerolymos, M., Galesic, K., Toric, L., Geddes, C., Siamopoulos, K., Balafa, O., Galliani, M., Stratta, P., Quaglia, M., Bergia, R., Cravero, R., Salvadori, M., Cirami, L., Fellstrom, B., Kloster Smerud, H., Ferrario, F., Stellato, T., Egido, J., Martin, C., Floege, J., Eitner, F., Lupo, A., Bernich, P., Menè, P., Morosetti, M., van Kooten, C., Rabelink, T., Reinders, M.E.J., Boria Grinyo, J.M., Cusinato, S., Benozzi, L., Savoldi, S., Licata, C., Mizerska-Wasiak, M., Roszkowska-Blaim, M., Hryszko, T., Klinger, M., Kamińska, D., Krajewska, M., Martina, G., Messuerotti, A., Dal Canton, A., Esposito, C., Migotto, C., Triolo, G., Mariano, F., Pozzi, C., Boero, R., Cambier, A., Bellur, S., Mazzucco, G., Giannakakis, C., Honsova, E., Sundelin, B., Di Palma, A.M., Diomedi-Casadei, F., Gutiérrez, E., Asunis, A.M., Barratt, J., Tardanico, R., Perkowska-Ptasinska, A., Arce Terroba, J., Fortunato, M., Pantzaki, A., Ozluk, Y., Steenbergen, E., Soderberg, M., Riispere, Z., Furci, L., Orhan, D., Kipgen, D., Casartelli, D., Galesic Ljubanovic, D., Gakiopoulou, H., Bertoni, E., Cannata Ortiz, P., Karkoszka, H., Groene, H.J., Stoppacciaro, A., Bajema, I., Bruijn, J., Fulladosa Oliveras, X., Maldyk, J., Ioachim, E., Royal, V., Bellur, Shubha S., Troyanov, Stéphan, Vorobyeva, Olga, Coppo, Rosanna, and Roberts, Ian S.D.
- Published
- 2024
- Full Text
- View/download PDF
3. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy
- Author
-
Russo, M.L., Troyanov, S., Cook, H.T., Roberts, I., Tesar, V., Maixnerova, D., Lundberg, S., Gesualdo, L., Emma, F., Fuiano, L., Beltrame, G., Rollino, C., Amore, A., Camilla, R., Peruzzi, L., Praga, M., Feriozzi, S., Polci, R., Segoloni, G., Colla, L., Pani, A., Piras, D., Angioi, A., Cancarini, G., Ravera, S., Durlik, M., Moggia, E., Ballarin, J., Di Giulio, S., Pugliese, F., Serriello, I., Caliskan, Y., Sever, M., Kilicaslan, I., Locatelli, F., Del Vecchio, L., Wetzels, J.F.M., Peters, H., Berg, U., Carvalho, F., da Costa Ferreira, A.C., Maggio, M., Wiecek, A., Ots-Rosenberg, M., Magistroni, R., Topaloglu, R., Bilginer, Y., D’Amico, M., Stangou, M., Giacchino, F., Goumenos, D., Papachristou, E., Galesic, K., Geddes, C., Siamopoulos, K., Balafa, O., Galliani, M., Stratta, P., Quaglia, M., Bergia, R., Cravero, R., Salvadori, M., Cirami, L., Fellstrom, B., Smerud, H. Kloster, Ferrario, F., Stellato, T., Egido, J., Martin, C., Floege, J., Eitner, F., Lupo, A., Bernich, P., Menè, P., Morosetti, M., van Kooten, C., Rabelink, T., Reinders, M.E.J., Boria Grinyo, J.M., Cusinato, S., Benozzi, L., Savoldi, S., Licata, C., Mizerska-Wasiak, M., Martina, G., Messuerotti, A., Dal Canton, A., Esposito, C., Migotto, C., Triolo, G., Mariano, F., Pozzi, C., Boero, R., Bellur, S., Mazzucco, G., Giannakakis, C., Honsova, E., Sundelin, B., Di Palma, A.M., Gutiérrez, E., Asunis, A.M., Barratt, J., Tardanico, R., Perkowska-Ptasinska, A., Terroba, J. Arce, Fortunato, M., Pantzaki, A., Ozluk, Y., Steenbergen, E., Soderberg, M., Riispere, Z., Furci, L., Orhan, D., Kipgen, D., Casartelli, D., Ljubanovic, D. Galesic, Gakiopoulou, H., Bertoni, E., Cannata Ortiz, P., Karkoszka, H., Groene, H.J., Stoppacciaro, A., Bajema, I., Bruijn, J., Fulladosa Oliveras, X., Maldyk, J., Ioachim, E., Bavbek, N., Cook, T., Alpers, C., Berthoux, F., Bonsib, S., D’Agati, V., D’Amico, G., Emancipator, S., Emmal, F., Fervenza, F., Florquin, S., Fogo, A., Groene, H., Haas, M., Hill, P., Hogg, R., Hsu, S., Hunley, T., Hladunewich, M., Jennette, C., Joh, K., Julian, B., Kawamura, T., Lai, F., Leung, C., Li, L., Li, P., Liu, Z., Massat, A., Mackinnon, B., Mezzano, S., Schena, F., Tomino, Y., Walker, P., Wang, H., Weening, J., Yoshikawa, N., Zeng, C.-H., Shi, S., Nogi, C., Suzuki, H., Koike, K., Hirano, K., Yokoo, T., Hanai, M., Fukami, K., Takahashi, K., Yuzawa, Y., Niwa, M., Yasuda, Y., Maruyama, S., Ichikawa, D., Suzuki, T., Shirai, S., Fukuda, A., Fujimoto, S., Trimarchi, H., Barbour, Sean J., Coppo, Rosanna, Zhang, Hong, Liu, Zhi-Hong, Suzuki, Yusuke, Matsuzaki, Keiichi, Er, Lee, Reich, Heather N., Barratt, Jonathan, and Cattran, Daniel C.
- Published
- 2022
- Full Text
- View/download PDF
4. Synthesis, X-ray Structures, and spectroscopic characterization of cis and trans-bis(O-propyldithiocarbonato)bis(pyridine)nickel(II), cis and trans-[Ni(CH3CH2CH2OC(S)S)2(C5H5N)2]
- Author
-
Juncal, Luciana C., Ferrer, Evelina G., Williams, Patricia A.M., Boese, Roland, Pozzi, C. Gustavo, Della Védova, Carlos O., and Romano, Rosana M.
- Published
- 2022
- Full Text
- View/download PDF
5. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy
- Author
-
Tesar, V., Maixnerova, D., Lundberg, S., Gesualdo, L., Emma, F., Fuiano, L., Beltrame, G., Rollino, C., Coppo, R., Amore, A., Camilla, R., Peruzzi, L., Praga, M., Feriozzi, S., Polci, R., Segoloni, G., Colla, L., Pani, A., Angioi, A., Piras, L., Feehally, J., Cancarini, G., Ravera, S., Durlik, M., Moggia, E., Ballarin, J., Di Giulio, S., Pugliese, F., Serriello, I., Caliskan, Y., Sever, M., Kilicaslan, I., Locatelli, F., Del Vecchio, L., Wetzels, J.F.M., Peters, H., Berg, U., Carvalho, F., da Costa Ferreira, A.C., Maggio, M., Wiecek, A., Ots-Rosenberg, M., Magistroni, R., Topaloglu, R., Bilginer, Y., D’Amico, M., Stangou, M., Giacchino, F., Goumenos, D., Papasotiriou, M., Galesic, K., Toric, L., Geddes, C., Siamopoulos, K., Balafa, O., Galliani, M., Stratta, P., Quaglia, M., Bergia, R., Cravero, R., Salvadori, M., Cirami, L., Fellstrom, B., Smerud, H. Kloster, Ferrario, F., Stellato, T., Egido, J., Martin, C., Floege, J., Eitner, F., Rauen, T., Lupo, A., Bernich, P., Menè, P., Morosetti, M., van Kooten, C., Rabelink, T., Reinders, M.E.J., Grinyo, J.M. Boria, Cusinato, S., Benozzi, L., Savoldi, S., Licata, C., Mizerska-Wasiak, M., Roszkowska-Blaim, M., Martina, G., Messuerotti, A., Canton, A. Dal, Esposito, C., Migotto, C., Triolo, G., Mariano, F., Pozzi, C., Boero, R., Mazzucco, Giannakakis, C., Honsova, E., Sundelin, B., Di Palma, A.M., Gutiérrez, E., Asunis, A.M., Barratt, J., Tardanico, R., Perkowska-Ptasinska, A., Terroba, J. Arce, Fortunato, M., Pantzaki, A., Ozluk, Y., Steenbergen, E., Soderberg, M., Riispere, Z., Furci, L., Orhan, D., Kipgen, D., Casartelli, D., GalesicLjubanovic, D., Gakiopoulou, H., Bertoni, E., Ortiz, P. Cannata, Karkoszka, H., Groene, H.J., Stoppacciaro, A., Bajema, I., Bruijn, J., FulladosaOliveras, X., Maldyk, J., Ioachim, E., Abbrescia, Daniela, Kouri, Nikoleta, Stangou, Maria, Papagianni, Aikaterini, Scolari, Francesco, Delbarba, Elisa, Bonomini, Mario, Piscitani, Luca, Stallone, Giovanni, Infante, Barbara, Godeas, Giulia, Madio, Desiree, Biancone, Luigi, Campagna, Marco, Zaza, Gianluigi, Squarzoni, Isabella, Cangemi, Concetta, Schena, Francesco Paolo, Anelli, Vito Walter, Trotta, Joseph, Di Noia, Tommaso, Manno, Carlo, Tripepi, Giovanni, D’Arrigo, Graziella, Chesnaye, Nicholas C., Russo, Maria Luisa, Zoccali, Carmine, Tesar, Vladimir, and Coppo, Rosanna
- Published
- 2021
- Full Text
- View/download PDF
6. The 'Continu-A-mente' project: an interdisciplinary program to promote the continuity of care between hospital and community for people with dementia and their caregivers. Study Protocol
- Author
-
Pozzi, C, Staglianò, A, Ballabio, C, Ponti, C, Bartoli, F, Antolini, L, Ferrara, M, Morandi, A, Cavalli, S, Gitlin, L, Bellelli, G, Pozzi, Christian, Staglianò, Andrea, Ballabio, Claudia, Ponti, Chiara, Bartoli, Federica, Antolini, Laura, Ferrara, Maria, Morandi, Alessandro, Cavalli, Stefano, Gitlin, Laura, Bellelli, Giuseppe, Pozzi, C, Staglianò, A, Ballabio, C, Ponti, C, Bartoli, F, Antolini, L, Ferrara, M, Morandi, A, Cavalli, S, Gitlin, L, Bellelli, G, Pozzi, Christian, Staglianò, Andrea, Ballabio, Claudia, Ponti, Chiara, Bartoli, Federica, Antolini, Laura, Ferrara, Maria, Morandi, Alessandro, Cavalli, Stefano, Gitlin, Laura, and Bellelli, Giuseppe
- Abstract
Background: Nonpharmacological approaches are recommended as first-line treatment for the neuropsychiatric symptoms of persons living with dementia. Tailored Activity Program is a non-pharmacological approach which has shown to reduce neuropsychiatric symptoms and functional dependence of persons living with dementia at the community, as well as caregiver’s distress. The aim of the study is to assess the feasibility of a project in which the Tailored Activity Program is delivered partially at an acute hospital ward and partially at the patient's home. Material and Methods: The study is aimed at enrolling 50 dyads (patients/caregivers) from the memory clinic, acute geriatric ward, or short-stay emergency department at the IRCCS San Gerardo dei Tintori, Monza (Italy). Inclusion criteria are: the patient’s clinical diagnosis of dementia, clinically detectable neuropsychiatric symptoms (Neuro Psychiatric Inventory, NPI score >6 in at least one item), the ability to participate in activities of daily living (Katz’s index ≥ 2), the presence of a caregiver (aged ≥ 21 years; minimum 4 hours of daily care), and the willingness of the dyad patient/caregiver to participate in the project. Treatment is delivered both i) in hospital (2 sessions) and ii) at home (6 sessions), including occupational therapy, telemedicine and nursing care provided once a week. The following variables are measured: Neuro Psychiatric Inventory, Time Up and Go Test, Katz’s Index and the level of caregiver’s sense of competence with the Sense of Competence Questionnaire. Data are collected both at baseline, at the end of the treatment, with a follow-up scheduled at 4 months after enrollment. Primary outcome measure is the dyad's retention rate at 4-month follow-up. Secondary outcomes are the reduction in the patient’s frequency and severity of NPS; the improvement in the patient’s Time Up and Go Test score; the improvement in the patient's levels of autonomy and participation in activities of daily
- Published
- 2024
7. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool
- Author
-
Russo, M.L., Troyanov, S., Cook, H.T., Roberts, I., Tesar, V., Maixnerova, D., Lundberg, S., Gesualdo, L., Emma, F., Fuiano, L., Beltrame, G., Rollino, C., Amore, A., Camilla, R., Peruzzi, L., Praga, M., Feriozzi, S., Polci, R., Segoloni, G., Colla, L., Pani, A., Piras, D., Angioi, A., Cancarini, G., Ravera, S., Durlik, M., Moggia, E., Ballarin, J., Di Giulio, S., Pugliese, F., Serriello, I., Caliskan, Y., Sever, M., Kilicaslan, I., Locatelli, F., Del Vecchio, L., Wetzels, J.F.M., Peters, H., Berg, U., Carvalho, F., da Costa Ferreira, A.C., Maggio, M., Wiecek, A., Ots-Rosenberg, M., Magistroni, R., Topaloglu, R., Bilginer, Y., D’Amico, M., Stangou, M., Giacchino, F., Goumenos, D., Kalliakmani, P., Gerolymos, M., Galesic, K., Geddes, C., Siamopoulos, K., Balafa, O., Galliani, M., Stratta, P., Quaglia, M., Bergia, R., Cravero, R., Salvadori, M., Cirami, L., Fellstrom, B., Kloster Smerud, H., Ferrario, F., Stellato, T., Egido, J., Martin, C., Floege, J., Eitner, F., Lupo, A., Bernich, P., Menè, P., Morosetti, M., van Kooten, C., Rabelink, T., Reinders, M.E.J., Boria Grinyo, J.M., Cusinato, S., Benozzi, L., Savoldi, S., Licata, C., Mizerska-Wasiak, M., Martina, G., Messuerotti, A., Dal Canton, A., Esposito, C., Migotto, C., Triolo, G., Mariano, F., Pozzi, C., Boero, R., Bellur, S., Mazzucco, G., Giannakakis, C., Honsova, E., Sundelin, B., Di Palma, A.M., Gutiérrez, E., Asunis, A.M., Barratt, J., Tardanico, R., Perkowska-Ptasinska, A., Arce Terroba, J., Fortunato, M., Pantzaki, A., Ozluk, Y., Steenbergen, E., Soderberg, M., Riispere, Z., Furci, L., Orhan, D., Kipgen, D., Casartelli, D., Galesic Ljubanovic, D., Gakiopoulou, H., Bertoni, E., Cannata Ortiz, P., Karkoszka, H., Groene, H.J., Stoppacciaro, A., Bajema, I., Bruijn, J., Fulladosa Oliveras, X., Maldyk, J., Ioachim, E., Bavbek, N., Cook, T., Alpers, C., Berthoux, F., Bonsib, S., D’Agati, V., D’Amico, G., Emancipator, S., Emmal, F., Fervenza, F., Florquin, S., Fogo, A., Groene, H., Haas, M., Hill, P., Hogg, R., Hsu, S., Hunley, T., Hladunewich, M., Jennette, C., Joh, K., Julian, B., Kawamura, T., Lai, F., Leung, C., Li, L., Li, P., Liu, Z., Massat, A., Mackinnon, B., Mezzano, S., Schena, F., Tomino, Y., Walker, P., Wang, H., Weening, J., Yoshikawa N, N., Zeng, C.-H., Shi, S., Nogi, C., Suzuki, H., Koike, K., Hirano, K., Yokoo, T., Hanai, M., Fukami, K., Takahashi, K., Yuzawa, Y., Niwa, M., Yasuda, Y., Maruyama, S., Ichikawa, D., Suzuki, T., Shirai, S., Fukuda, A., Fujimoto, S., Trimarchi, H., Barbour, Sean J., Canney, Mark, Coppo, Rosanna, Zhang, Hong, Liu, Zhi-Hong, Suzuki, Yusuke, Matsuzaki, Keiichi, Katafuchi, Ritsuko, Induruwage, Dilshani, Er, Lee, Reich, Heather N., Feehally, John, Barratt, Jonathan, and Cattran, Daniel C.
- Published
- 2020
- Full Text
- View/download PDF
8. Emerging disease modifying therapies for older adults with Alzheimer disease: perspectives from the EuGMS special interest group in dementia
- Author
-
Dyer, A, Dolphin, H, Shenkin, S, Welsh, T, Soysal, P, Roitto, H, Religa, D, Kennelly, S, Soylemez, B, Alves, M, Atbas, C, Balci, C, Bellelli, G, Blanc, F, Cavusoglu, C, Chen, Y, Cherdak, M, Coin, A, Cozza, M, Dangiolo, M, Dani, M, Dogu, B, Du, J, Eleftheriades, C, Frisardi, V, Froelich, L, Guney, S, Harwood, R, Huang, A, Isaev, R, Okudur, S, Leroy, V, Luis, M, Macijauskiene, J, Milosavljevik, P, Mkhitaryan, E, Molnar, F, Mossello, E, Passmore, P, Peeters, G, Pozzi, C, Quinn, T, Rahman, S, Rosendahl, E, Roy, A, Sizoo, E, Smith, L, Tannou, T, Tatzer, V, Timmons, S, Tournoy, J, Valimaki, T, Velevska, M, Vardy, E, Veronese, N, Zamfir, M, Dyer A. H., Dolphin H., Shenkin S. D., Welsh T., Soysal P., Roitto H. -M., Religa D., Kennelly S. P., Soylemez B. A., Alves M., Atbas C., Balci C., Bellelli G., Blanc F., Cavusoglu C., Chen Y., Cherdak M., Coin A., Cozza M. G., Dangiolo M., Dani M., Dogu B. B., Du J., Eleftheriades C., Frisardi V., Froelich L., Guney S., Harwood R. H., Huang A., Isaev R., Okudur S. K., Leroy V., Luis M. M., Macijauskiene J., Milosavljevik P., Mkhitaryan E., Molnar F., Mossello E., Passmore P., Peeters G., Pozzi C., Quinn T., Rahman S., Rosendahl E., Roy A., Sizoo E., Smith L., Tannou T., Tatzer V., Timmons S., Tournoy J., Valimaki T., Velevska M., Vardy E., Veronese N., Zamfir M., Dyer, A, Dolphin, H, Shenkin, S, Welsh, T, Soysal, P, Roitto, H, Religa, D, Kennelly, S, Soylemez, B, Alves, M, Atbas, C, Balci, C, Bellelli, G, Blanc, F, Cavusoglu, C, Chen, Y, Cherdak, M, Coin, A, Cozza, M, Dangiolo, M, Dani, M, Dogu, B, Du, J, Eleftheriades, C, Frisardi, V, Froelich, L, Guney, S, Harwood, R, Huang, A, Isaev, R, Okudur, S, Leroy, V, Luis, M, Macijauskiene, J, Milosavljevik, P, Mkhitaryan, E, Molnar, F, Mossello, E, Passmore, P, Peeters, G, Pozzi, C, Quinn, T, Rahman, S, Rosendahl, E, Roy, A, Sizoo, E, Smith, L, Tannou, T, Tatzer, V, Timmons, S, Tournoy, J, Valimaki, T, Velevska, M, Vardy, E, Veronese, N, Zamfir, M, Dyer A. H., Dolphin H., Shenkin S. D., Welsh T., Soysal P., Roitto H. -M., Religa D., Kennelly S. P., Soylemez B. A., Alves M., Atbas C., Balci C., Bellelli G., Blanc F., Cavusoglu C., Chen Y., Cherdak M., Coin A., Cozza M. G., Dangiolo M., Dani M., Dogu B. B., Du J., Eleftheriades C., Frisardi V., Froelich L., Guney S., Harwood R. H., Huang A., Isaev R., Okudur S. K., Leroy V., Luis M. M., Macijauskiene J., Milosavljevik P., Mkhitaryan E., Molnar F., Mossello E., Passmore P., Peeters G., Pozzi C., Quinn T., Rahman S., Rosendahl E., Roy A., Sizoo E., Smith L., Tannou T., Tatzer V., Timmons S., Tournoy J., Valimaki T., Velevska M., Vardy E., Veronese N., and Zamfir M.
- Published
- 2023
9. Implementation of the Community Occupational Therapy in Dementia program in Italy (COTiD-IT): qualitative survey to identify barriers and facilitators in implementation
- Author
-
Lanzoni, A, Pozzi, C, Lucchi, E, Fabbo, A, Graff, M, Döpp, C, Lanzoni A., Pozzi C., Lucchi E., Fabbo A., Graff M. J. L., Döpp C. M. E., Lanzoni, A, Pozzi, C, Lucchi, E, Fabbo, A, Graff, M, Döpp, C, Lanzoni A., Pozzi C., Lucchi E., Fabbo A., Graff M. J. L., and Döpp C. M. E.
- Abstract
Background: Community Occupational Therapy in Dementia in Italy (COTID−IT) is a feasible and effective treatment that aims improving the quality of life and well−being of people with dementia and caregivers. The implementation of the program in the national context has not been studied yet. Aim: The objective of this study is to identify barriers and facilitators in the Italian implementation of the program. Methods: We designed a quantitative cross-sectional survey. A questionnaire was developed to collect descriptive data regarding the respondents, the perceived barriers and facilitators regarding the application of COTiD and possible actions to promote the implementation process. Results: The questionnaire was sent to all 90 Italian OTs trained in the use of COTiD−IT from 2013 to 2020. 50 people responded (61%). Barriers to the implementation of the COTID−IT included lack of knowledge about Occupational Therapy and the COTID−IT program by other health professionals. In addition, the scarcity of economic funds invested in home rehabilitation is experienced as another significant barrier. Facilitators were found to be the presence of an interprofessional team interested in the COTID−IT program and occupational therapy and the fact that COTID−IT is supported by scientific evidence. The creation of national and regional inter professional education and support groups, the availability of online resources are seen as opportunities to better implement the COTID−IT program. Conclusions: Implementation of psychosocial interventions is complex. OTs in Italy should be increasingly included within health policies and care programs of people with dementia to promote the use of COTID−IT. Further studies are needed to detail the policy and methodological actions that OTs should take in the future to disseminate and consolidate this intervention.
- Published
- 2023
10. Targeting class A and C serine β-lactamases with a broad-spectrum boronic acid derivative
- Author
-
Shoichet, Brian, Tondi, D, Venturelli, A, Bonnet, R, Pozzi, C, Shoichet, BK, and Costi, MP
- Abstract
Production of β-lactamases (BLs) is the most widespread resistance mechanism adopted by bacteria to fight β-lactam antibiotics. The substrate spectrum of BLs has become increasingly broad, posing a serious health problem. Thus, there is an urgent need for
- Published
- 2014
11. The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease
- Author
-
Massy Z. A., Chesnaye N. C., Larabi I. A., Dekker F. W., Evans M., Caskey F. J., Torino C., Porto G., Szymczak M., Drechsler C., Wanner C., Jager K. J., Alvarez J. C., Schneider A., Torp A., Iwig B., Perras B., Marx C., Blaser C., Emde C., Krieter D., Fuchs D., Irmler E., Platen E., Schmidt-Gurtler H., Schlee H., Naujoks H., Schlee I., Casar S., Beige J., Rothele J., Mazur J., Hahn K., Blouin K., Neumeier K., Anding-Rost K., Schramm L., Hopf M., Wuttke N., Frischmuth N., Ichtiaris P., Kirste P., Schulz P., Aign S., Biribauer S., Manan S., Roser S., Heidenreich S., Palm S., Schwedler S., Delrieux S., Renker S., Schattel S., Stephan T., Schmiedeke T., Weinreich T., Leimbach T., Stovesand T., Bahner U., Seeger W., Cupisti A., Sagliocca A., Ferraro A., Mele A., Naticchia A., Cosaro A., Ranghino A., Stucchi A., Pignataro A., De Blasio A., Pani A., Tsalouichos A., Bellasi A., Raffaele Di Iorio B., Butti A., Abaterusso C., Somma C., D'Alessandro C., Zullo C., Pozzi C., Bergamo D., Ciurlino D., Motta D., Russo D., Favaro E., Vigotti F., Ansali F., Conte F., Cianciotta F., Giacchino F., Cappellaio F., Pizzarelli F., Greco G., Bigatti G., Marinangeli G., Cabiddu G., Fumagalli G., Caloro G., Piccoli G., Capasso G., Gambaro G., Tognarelli G., Bonforte G., Conte G., Toscano G., Del Rosso G., Capizzi I., Baragetti I., Oldrizzi L., Gesualdo L., Biancone L., Magnano M., Ricardi M., Di Bari M., Laudato M., Luisa Sirico M., Ferraresi M., Provenzano M., Malaguti M., Palmieri N., Murrone P., Cirillo P., Dattolo P., Acampora P., Nigro R., Boero R., Scarpioni R., Sicoli R., Malandra R., Savoldi S., Bertoli S., Borrelli S., Maxia S., Maffei S., Mangano S., Cicchetti T., Rappa T., Palazzo V., De Simone W., Schrander A., Van Dam B., Siegert C., Gaillard C., Beerenhout C., Verburgh C., Janmaat C., Hoogeveen E., Hoorn E., Boots J., Boom H., Eijgenraam J. -W., Kooman J., Rotmans J., Vogt L., Raasveld M., Vervloet M., Van Buren M., Van Diepen M., Leurs P., Voskamp P., Blankestijn P., Van Esch S., Boorsma S., Berger S., Konings C., Aydin Z., Musiala A., Szymczak A., Olczyk E., Augustyniak-Bartosik H., Miskowiec-Wisniewska I., Manitius J., Pondel J., Jedrzejak K., Nowanska K., Nowak L., Durlik M., Dorota S., Nieszporek T., Heleniak Z., Jonsson A., Blom A. -L., Rogland B., Wallquist C., Vargas D., Dimeny E., Sundelin F., Uhlin F., Welander G., Bascaran Hernandez I., Grontoft K. -C., Stendahl M., Svensson M., Heimburger O., Kashioulis P., Melander S., Almquist T., Jensen U., Woodman A., McKeever A., Ullah A., McLaren B., Harron C., Barrett C., O'Toole C., Summersgill C., Geddes C., Glowski D., McGlynn D., Sands D., Roy G., Hirst G., King H., McNally H., Masri-Senghor H., Murtagh H., Rayner H., Turner J., Wilcox J., Berdeprado J., Wong J., Banda J., Jones K., Haydock L., Wilkinson L., Carmody M., Weetman M., Joinson M., Dutton M., Matthews M., Morgan N., Bleakley N., Cockwell P., Roderick P., Mason P., Kalra P., Sajith R., Chapman S., Navjee S., Crosbie S., Brown S., Tickle S., Mathavakkannan S., Kuan Y., Massy, Z. A., Chesnaye, N. C., Larabi, I. A., Dekker, F. W., Evans, M., Caskey, F. J., Torino, C., Porto, G., Szymczak, M., Drechsler, C., Wanner, C., Jager, K. J., Alvarez, J. C., Schneider, A., Torp, A., Iwig, B., Perras, B., Marx, C., Blaser, C., Emde, C., Krieter, D., Fuchs, D., Irmler, E., Platen, E., Schmidt-Gurtler, H., Schlee, H., Naujoks, H., Schlee, I., Casar, S., Beige, J., Rothele, J., Mazur, J., Hahn, K., Blouin, K., Neumeier, K., Anding-Rost, K., Schramm, L., Hopf, M., Wuttke, N., Frischmuth, N., Ichtiaris, P., Kirste, P., Schulz, P., Aign, S., Biribauer, S., Manan, S., Roser, S., Heidenreich, S., Palm, S., Schwedler, S., Delrieux, S., Renker, S., Schattel, S., Stephan, T., Schmiedeke, T., Weinreich, T., Leimbach, T., Stovesand, T., Bahner, U., Seeger, W., Cupisti, A., Sagliocca, A., Ferraro, A., Mele, A., Naticchia, A., Cosaro, A., Ranghino, A., Stucchi, A., Pignataro, A., De Blasio, A., Pani, A., Tsalouichos, A., Bellasi, A., Raffaele Di Iorio, B., Butti, A., Abaterusso, C., Somma, C., D'Alessandro, C., Zullo, C., Pozzi, C., Bergamo, D., Ciurlino, D., Motta, D., Russo, D., Favaro, E., Vigotti, F., Ansali, F., Conte, F., Cianciotta, F., Giacchino, F., Cappellaio, F., Pizzarelli, F., Greco, G., Bigatti, G., Marinangeli, G., Cabiddu, G., Fumagalli, G., Caloro, G., Piccoli, G., Capasso, G., Gambaro, G., Tognarelli, G., Bonforte, G., Conte, G., Toscano, G., Del Rosso, G., Capizzi, I., Baragetti, I., Oldrizzi, L., Gesualdo, L., Biancone, L., Magnano, M., Ricardi, M., Di Bari, M., Laudato, M., Luisa Sirico, M., Ferraresi, M., Provenzano, M., Malaguti, M., Palmieri, N., Murrone, P., Cirillo, P., Dattolo, P., Acampora, P., Nigro, R., Boero, R., Scarpioni, R., Sicoli, R., Malandra, R., Savoldi, S., Bertoli, S., Borrelli, S., Maxia, S., Maffei, S., Mangano, S., Cicchetti, T., Rappa, T., Palazzo, V., De Simone, W., Schrander, A., Van Dam, B., Siegert, C., Gaillard, C., Beerenhout, C., Verburgh, C., Janmaat, C., Hoogeveen, E., Hoorn, E., Boots, J., Boom, H., Eijgenraam, J. -W., Kooman, J., Rotmans, J., Vogt, L., Raasveld, M., Vervloet, M., Van Buren, M., Van Diepen, M., Leurs, P., Voskamp, P., Blankestijn, P., Van Esch, S., Boorsma, S., Berger, S., Konings, C., Aydin, Z., Musiala, A., Szymczak, A., Olczyk, E., Augustyniak-Bartosik, H., Miskowiec-Wisniewska, I., Manitius, J., Pondel, J., Jedrzejak, K., Nowanska, K., Nowak, L., Durlik, M., Dorota, S., Nieszporek, T., Heleniak, Z., Jonsson, A., Blom, A. -L., Rogland, B., Wallquist, C., Vargas, D., Dimeny, E., Sundelin, F., Uhlin, F., Welander, G., Bascaran Hernandez, I., Grontoft, K. -C., Stendahl, M., Svensson, M., Heimburger, O., Kashioulis, P., Melander, S., Almquist, T., Jensen, U., Woodman, A., Mckeever, A., Ullah, A., Mclaren, B., Harron, C., Barrett, C., O'Toole, C., Summersgill, C., Geddes, C., Glowski, D., Mcglynn, D., Sands, D., Roy, G., Hirst, G., King, H., Mcnally, H., Masri-Senghor, H., Murtagh, H., Rayner, H., Turner, J., Wilcox, J., Berdeprado, J., Wong, J., Banda, J., Jones, K., Haydock, L., Wilkinson, L., Carmody, M., Weetman, M., Joinson, M., Dutton, M., Matthews, M., Morgan, N., Bleakley, N., Cockwell, P., Roderick, P., Mason, P., Kalra, P., Sajith, R., Chapman, S., Navjee, S., Crosbie, S., Brown, S., Tickle, S., Mathavakkannan, S., Kuan, Y., Nephrology, ACS - Diabetes & metabolism, Medical Informatics, APH - Methodology, APH - Aging & Later Life, APH - Quality of Care, APH - Global Health, APH - Health Behaviors & Chronic Diseases, and ACS - Pulmonary hypertension & thrombosis
- Subjects
Transplantation ,Nephrology ,uremic toxins ,CKD ,symptoms ,symptom ,elderly - Abstract
Background Patients with stage 4/5 chronic kidney disease (CKD) suffer from various symptoms. The retention of uremic solutes is thought to be associated with those symptoms. However, there are relatively few rigorous studies on the potential links between uremic toxins and symptoms in patients with CKD. Methods The EQUAL study is an ongoing observational cohort study of non-dialyzed patients with stage 4/5 CKD. EQUAL patients from Germany, Poland, Sweden and the UK were included in the present study (n = 795). Data and symptom self-report questionnaires were collected between April 2012 and September 2020. Baseline uric acid and parathyroid hormone and 10 uremic toxins were quantified. We tested the association between uremic toxins and symptoms and adjusted P-values for multiple testing. Results Symptoms were more frequent in women than in men with stage 4/5 CKD, while levels of various uremic toxins were higher in men. Only trimethylamine N-oxide (TMAO; positive association with fatigue), p-cresyl sulfate (PCS) with constipation and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (negative association with shortness of breath) demonstrated moderately strong associations with symptoms in adjusted analyses. The association of phenylacetylglutamine with shortness of breath was consistent in both sexes, although it only reached statistical significance in the full population. In contrast, TMAO (fatigue) and PCS and phenylacetylglutamine (constipation) were only associated with symptoms in men, who presented higher serum levels than women. Conclusion Only a limited number of toxins were associated with symptoms in persons with stage 4/5 CKD. Other uremic toxins, uremia-related factors or psychosocial factors not yet explored might contribute to symptom burden.
- Published
- 2022
12. Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients
- Author
-
Bellerba, F, Serrano, D, Harriet, J, Pozzi, C, Segata, N, Nabinejad, A, Piperni, E, Gnagnarella, P, Macis, D, Aristarco, V, Accornero, C, Manghi, P, Gonzaga, A, Biffi, R, Bottiglieri, L, Trovato, C, Zampino, M, Corso, F, Bellocco, R, Raimondi, S, Rescigno, M, Gandini, S, Bellerba F., Serrano D., Harriet J., Pozzi C., Segata N., NabiNejad A., Piperni E., Gnagnarella P., Macis D., Aristarco V., Accornero C. A., Manghi P., Gonzaga A. G., Biffi R., Bottiglieri L., Trovato C., Zampino M. G., Corso F., Bellocco R., Raimondi S., Rescigno M., Gandini S., Bellerba, F, Serrano, D, Harriet, J, Pozzi, C, Segata, N, Nabinejad, A, Piperni, E, Gnagnarella, P, Macis, D, Aristarco, V, Accornero, C, Manghi, P, Gonzaga, A, Biffi, R, Bottiglieri, L, Trovato, C, Zampino, M, Corso, F, Bellocco, R, Raimondi, S, Rescigno, M, Gandini, S, Bellerba F., Serrano D., Harriet J., Pozzi C., Segata N., NabiNejad A., Piperni E., Gnagnarella P., Macis D., Aristarco V., Accornero C. A., Manghi P., Gonzaga A. G., Biffi R., Bottiglieri L., Trovato C., Zampino M. G., Corso F., Bellocco R., Raimondi S., Rescigno M., and Gandini S.
- Abstract
Background: Several studies suggest a role of gut microbiota in colorectal cancer (CRC) initiation and progression. Vitamin D (vitD) blood levels are also inversely correlated with CRC risk and prognosis. However, these factors’ interplay remains unknown. Methods: 74 CRC patients after standard treatment were randomized to 1-year 2000 IU/day vitD or placebo. Baseline and post-treatment fecal microbiota for shotgun metagenomics sequencing was collected. Coda-lasso and Principal Component Analysis were used to select and summarize treatment-associated taxa and pathways. Associations between vitD and taxa/pathways were investigated with logistic regression. Mediation analysis was performed to study if treatment-associated taxa mediated the effect of supplementation on 25(OH)D levels. Cox proportional-hazards model was used for disease-free survival (DFS). Results: 60 patients were analyzed. Change in alpha diversity (Shannon: p = 0.77; Simpson: p = 0.63) and post-treatment beta diversity (p = 0.70) were comparable between arms. Post-treatment abundances of 63 taxa and 32 pathways differed between arms. The 63 taxa also mediated the effect of supplementation on 25(OH)D (p = 0.02). There were sex differences in vitD levels, microbiota and pathways. Pathways of essential amino acids’ biosynthesis were more abundant in supplemented women. Fusobacterium nucleatum presence at baseline was associated with worse DFS (p = 0.02). Those achieving vitD sufficiency (25(OH)D≥30 ng/ml) had lower post-treatment abundances (p = 0.05). Women were more likely to have F. nucleatum post-treatment (p = 0.02). Conclusions: VitD supplementation may contribute shaping the gut microbiota and the microbiota may partially mediate the effect of supplementation on 25(OH)D. The observed sex-specific differences highlight the necessity of including sex/gender as a variable in microbiome studies.
- Published
- 2022
13. Implementation of the Community Occupational Therapy in Dementia program in Italy (COTiD-IT): qualitative survey to identify barriers and facilitators in implementation.
- Author
-
Lanzoni, A., Pozzi, C., Lucchi, E., Fabbo, A., Graff, M.J.L., Döpp, C.M.E., Lanzoni, A., Pozzi, C., Lucchi, E., Fabbo, A., Graff, M.J.L., and Döpp, C.M.E.
- Abstract
01 januari 2023, Item does not contain fulltext, BACKGROUND: Community Occupational Therapy in Dementia in Italy (COTID-IT) is a feasible and effective treatment that aims improving the quality of life and well-being of people with dementia and caregivers. The implementation of the program in the national context has not been studied yet. AIM: The objective of this study is to identify barriers and facilitators in the Italian implementation of the program. METHODS: We designed a quantitative cross-sectional survey. A questionnaire was developed to collect descriptive data regarding the respondents, the perceived barriers and facilitators regarding the application of COTiD and possible actions to promote the implementation process. RESULTS: The questionnaire was sent to all 90 Italian OTs trained in the use of COTiD-IT from 2013 to 2020. 50 people responded (61%). Barriers to the implementation of the COTID-IT included lack of knowledge about Occupational Therapy and the COTID-IT program by other health professionals. In addition, the scarcity of economic funds invested in home rehabilitation is experienced as another significant barrier. Facilitators were found to be the presence of an interprofessional team interested in the COTID-IT program and occupational therapy and the fact that COTID-IT is supported by scientific evidence. The creation of national and regional inter professional education and support groups, the availability of online resources are seen as opportunities to better implement the COTID-IT program. CONCLUSIONS: Implementation of psychosocial interventions is complex. OTs in Italy should be increasingly included within health policies and care programs of people with dementia to promote the use of COTID-IT. Further studies are needed to detail the policy and methodological actions that OTs should take in the future to disseminate and consolidate this intervention.
- Published
- 2023
14. Innovative Non-Pharmacological Management of Delirium in Persons with Dementia: New Frontiers for Physiotherapy and Occupational Therapy?
- Author
-
Pozzi, C, Tatzer, V, Strasser-Gugerell, C, Cavalli, S, Morandi, A, Bellelli, G, Tatzer, VC, Pozzi, C, Tatzer, V, Strasser-Gugerell, C, Cavalli, S, Morandi, A, Bellelli, G, and Tatzer, VC
- Abstract
Background: Delirium and dementia are two of the most common geriatric syndromes, which requires innovative rehabilitation approaches. Aim: We aimed at determining which occupational therapy and physiotherapy interventions are applied with older people with delirium and dementia in different care settings. We also identified the assessment tools that were used. Materials and methods: We conducted a literature search for scientific articles published from 2012 to 2022 (PubMed, MEDLINE, AMED and CINAHL) with adults aged >65 years including experimental study designs with randomized or non-randomized intervention, exploratory studies, pilot studies, quasi-experimental studies, case series and/or clinical cases. Studies that did not use interventions that could be classified as occupational therapy or physiotherapy were excluded. Results: After applying the exclusion criteria, 9 articles were selected. The most widely used assessment to define dementia was the MMSE (N = 5; 55.5%), whereas the CAM (N = 2; 22.2%), CAM-ICU (N = 2; 22.2%) and RASS (N = 3; 33.3%) were the most widely used to define delirium. The rehabilitation interventions that were most frequently performed were early mobilization, inclusion of the caregiver during treatment, modification of the environment to encourage orientation and autonomy, the interprofessional systemic approach and engaging persons in meaningful activities. Conclusions: Despite the growing evidence on its effectiveness, the role of physiotherapy and occupational therapy interventions in the prevention and treatment of people with dementia and delirium is still emerging. More research is needed to investigate if effective occupational therapy programs known to reduce the behavioral and psychological symptoms in people with dementia are also useful for treating delirium and specifically delirium superimposed on dementia. Regarding physiotherapy, it is crucial to know about the amount and timing of intervention required. Further stu
- Published
- 2023
15. Real-world automotive particulate matter and PAH emission factors and profile concentrations: Results from an urban tunnel experiment in Naples, Italy
- Author
-
Riccio, A., Chianese, E., Monaco, D., Costagliola, M.A., Perretta, G., Prati, M.V., Agrillo, G., Esposito, A., Gasbarra, D., Shindler, L., Brusasca, G., Nanni, A., Pozzi, C., and Magliulo, V.
- Published
- 2016
- Full Text
- View/download PDF
16. Alteration of taste perception, food neophobia and oral microbiota composition in children with food allergy
- Author
-
D'Auria, E., Cattaneo, C., Panelli, S., Pozzi, C., Acunzo, M., Papaleo, S., Comandatore, F., Mameli, C., Bandi, C., Zuccotti, G., and Pagliarini, E.
- Subjects
Settore MED/38 - Pediatria Generale e Specialistica ,Settore AGR/15 - Scienze e Tecnologie Alimentari ,Settore BIO/19 - Microbiologia Generale - Published
- 2023
17. Crystal structure of TRIM33 alpha PHD-Bromo domain in complex with 9
- Author
-
Tassone, G., primary, Pozzi, C., additional, and Palomba, T., additional
- Published
- 2022
- Full Text
- View/download PDF
18. Crystal structure of TRIM33 alpha PHD-Bromo domain in complex with 10
- Author
-
Tassone, G., primary, Pozzi, C., additional, and Palomba, T., additional
- Published
- 2022
- Full Text
- View/download PDF
19. Crystal structure of TRIM33 alpha PHD-Bromo domain in complex with 8
- Author
-
Tassone, G., primary, Pozzi, C., additional, and Palomba, T., additional
- Published
- 2022
- Full Text
- View/download PDF
20. C-type lectin-like domain (CTLD) and Sushi-like domain of human CD93
- Author
-
Tassone, G., primary, Barbera, S., additional, Raucci, L., additional, Orlandini, M., additional, and Pozzi, C., additional
- Published
- 2022
- Full Text
- View/download PDF
21. Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112A in complex with JMC31
- Author
-
Tassone, G., primary, Pozzi, C., additional, Mazzorana, M., additional, Mangani, S., additional, and Maramai, S., additional
- Published
- 2022
- Full Text
- View/download PDF
22. Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) in complex with JMC31
- Author
-
Tassone, G., primary, Pozzi, C., additional, Mazzorana, M., additional, Mangani, S., additional, and Maramai, S., additional
- Published
- 2022
- Full Text
- View/download PDF
23. Competing intramolecular N[sbnd]H[formula omitted]O[dbnd]C hydrogen bonds and extended intermolecular network in 1-(4-chlorobenzoyl)-3-(2-methyl-4-oxopentan-2-yl) thiourea analyzed by experimental and theoretical methods
- Author
-
Saeed, Aamer, Khurshid, Asma, Jasinski, Jerry P., Pozzi, C. Gustavo, Fantoni, Adolfo C., and Erben, Mauricio F.
- Published
- 2014
- Full Text
- View/download PDF
24. Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial
- Author
-
Ruggenenti, P, Podesta, M, Trillini, M, Perna, A, Peracchi, T, Rubis, N, Villa, D, Martinetti, D, Cortinovis, M, Ondei, P, Condemi, C, Guastoni, C, Meterangelis, A, Granata, A, Mambelli, E, Pasquali, S, Genovesi, S, Pieruzzi, F, Bertoli, S, Del Rosso, G, Garozzo, M, Rigotti, A, Pozzi, C, David, S, Daidone, G, Mingardi, G, Mosconi, G, Galfre, A, Romei Longhena, G, Pacitti, A, Pani, A, Hidalgo Godoy, J, Anders, H, Remuzzi, G, Ruggenenti P., Podesta M. A., Trillini M., Perna A., Peracchi T., Rubis N., Villa D., Martinetti D., Cortinovis M., Ondei P., Condemi C. G., Guastoni C. M., Meterangelis A., Granata A., Mambelli E., Pasquali S., Genovesi S., Pieruzzi F., Bertoli S. V., Del Rosso G., Garozzo M., Rigotti A., Pozzi C., David S., Daidone G., Mingardi G., Mosconi G., Galfre A., Romei Longhena G., Pacitti A., Pani A., Hidalgo Godoy J., Anders H. -J., Remuzzi G., Ruggenenti, P, Podesta, M, Trillini, M, Perna, A, Peracchi, T, Rubis, N, Villa, D, Martinetti, D, Cortinovis, M, Ondei, P, Condemi, C, Guastoni, C, Meterangelis, A, Granata, A, Mambelli, E, Pasquali, S, Genovesi, S, Pieruzzi, F, Bertoli, S, Del Rosso, G, Garozzo, M, Rigotti, A, Pozzi, C, David, S, Daidone, G, Mingardi, G, Mosconi, G, Galfre, A, Romei Longhena, G, Pacitti, A, Pani, A, Hidalgo Godoy, J, Anders, H, Remuzzi, G, Ruggenenti P., Podesta M. A., Trillini M., Perna A., Peracchi T., Rubis N., Villa D., Martinetti D., Cortinovis M., Ondei P., Condemi C. G., Guastoni C. M., Meterangelis A., Granata A., Mambelli E., Pasquali S., Genovesi S., Pieruzzi F., Bertoli S. V., Del Rosso G., Garozzo M., Rigotti A., Pozzi C., David S., Daidone G., Mingardi G., Mosconi G., Galfre A., Romei Longhena G., Pacitti A., Pani A., Hidalgo Godoy J., Anders H. -J., and Remuzzi G.
- Abstract
BACKGROUND AND OBJECTIVES: Renin-angiotensin system (RAS) inhibitors reduce cardiovascular morbidity and mortality in patients with CKD. We evaluated the cardioprotective effects of the angiotensin-converting enzyme inhibitor ramipril in patients on maintenance hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this phase 3, prospective, randomized, open-label, blinded end point, parallel, multicenter trial, we recruited patients on maintenance hemodialysis with hypertension and/or left ventricular hypertrophy from 28 Italian centers. Between July 2009 and February 2014, 140 participants were randomized to ramipril (1.25-10 mg/d) and 129 participants were allocated to non-RAS inhibition therapy, both titrated up to the maximally tolerated dose to achieve predefined target BP values. The primary efficacy end point was a composite of cardiovascular death, myocardial infarction, or stroke. Secondary end points included the single components of the primary end point, new-onset or recurrence of atrial fibrillation, hospitalizations for symptomatic fluid overload, thrombosis or stenosis of the arteriovenous fistula, and changes in cardiac mass index. All outcomes were evaluated up to 42 months after randomization. RESULTS: At comparable BP control, 23 participants on ramipril (16%) and 24 on non-RAS inhibitor therapy (19%) reached the primary composite end point (hazard ratio, 0.93; 95% confidence interval, 0.52 to 1.64; P=0.80). Ramipril reduced cardiac mass index at 1 year of follow-up (between-group difference in change from baseline: -16.3 g/m2; 95% confidence interval, -29.4 to -3.1), but did not significantly affect the other secondary outcomes. Hypotensive episodes were more frequent in participants allocated to ramipril than controls (41% versus 12%). Twenty participants on ramipril and nine controls developed cancer, including six gastrointestinal malignancies on ramipril (four were fatal), compared with none in controls. CONCLUSIONS: Ramipril di
- Published
- 2021
25. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy
- Author
-
Barbour, Sean J., primary, Coppo, Rosanna, additional, Zhang, Hong, additional, Liu, Zhi-Hong, additional, Suzuki, Yusuke, additional, Matsuzaki, Keiichi, additional, Er, Lee, additional, Reich, Heather N., additional, Barratt, Jonathan, additional, Cattran, Daniel C., additional, Russo, M.L., additional, Troyanov, S., additional, Cook, H.T., additional, Roberts, I., additional, Tesar, V., additional, Maixnerova, D., additional, Lundberg, S., additional, Gesualdo, L., additional, Emma, F., additional, Fuiano, L., additional, Beltrame, G., additional, Rollino, C., additional, Amore, A., additional, Camilla, R., additional, Peruzzi, L., additional, Praga, M., additional, Feriozzi, S., additional, Polci, R., additional, Segoloni, G., additional, Colla, L., additional, Pani, A., additional, Piras, D., additional, Angioi, A., additional, Cancarini, G., additional, Ravera, S., additional, Durlik, M., additional, Moggia, E., additional, Ballarin, J., additional, Di Giulio, S., additional, Pugliese, F., additional, Serriello, I., additional, Caliskan, Y., additional, Sever, M., additional, Kilicaslan, I., additional, Locatelli, F., additional, Del Vecchio, L., additional, Wetzels, J.F.M., additional, Peters, H., additional, Berg, U., additional, Carvalho, F., additional, da Costa Ferreira, A.C., additional, Maggio, M., additional, Wiecek, A., additional, Ots-Rosenberg, M., additional, Magistroni, R., additional, Topaloglu, R., additional, Bilginer, Y., additional, D’Amico, M., additional, Stangou, M., additional, Giacchino, F., additional, Goumenos, D., additional, Papachristou, E., additional, Galesic, K., additional, Geddes, C., additional, Siamopoulos, K., additional, Balafa, O., additional, Galliani, M., additional, Stratta, P., additional, Quaglia, M., additional, Bergia, R., additional, Cravero, R., additional, Salvadori, M., additional, Cirami, L., additional, Fellstrom, B., additional, Smerud, H. Kloster, additional, Ferrario, F., additional, Stellato, T., additional, Egido, J., additional, Martin, C., additional, Floege, J., additional, Eitner, F., additional, Lupo, A., additional, Bernich, P., additional, Menè, P., additional, Morosetti, M., additional, van Kooten, C., additional, Rabelink, T., additional, Reinders, M.E.J., additional, Boria Grinyo, J.M., additional, Cusinato, S., additional, Benozzi, L., additional, Savoldi, S., additional, Licata, C., additional, Mizerska-Wasiak, M., additional, Martina, G., additional, Messuerotti, A., additional, Dal Canton, A., additional, Esposito, C., additional, Migotto, C., additional, Triolo, G., additional, Mariano, F., additional, Pozzi, C., additional, Boero, R., additional, Bellur, S., additional, Mazzucco, G., additional, Giannakakis, C., additional, Honsova, E., additional, Sundelin, B., additional, Di Palma, A.M., additional, Gutiérrez, E., additional, Asunis, A.M., additional, Barratt, J., additional, Tardanico, R., additional, Perkowska-Ptasinska, A., additional, Terroba, J. Arce, additional, Fortunato, M., additional, Pantzaki, A., additional, Ozluk, Y., additional, Steenbergen, E., additional, Soderberg, M., additional, Riispere, Z., additional, Furci, L., additional, Orhan, D., additional, Kipgen, D., additional, Casartelli, D., additional, Ljubanovic, D. Galesic, additional, Gakiopoulou, H., additional, Bertoni, E., additional, Cannata Ortiz, P., additional, Karkoszka, H., additional, Groene, H.J., additional, Stoppacciaro, A., additional, Bajema, I., additional, Bruijn, J., additional, Fulladosa Oliveras, X., additional, Maldyk, J., additional, Ioachim, E., additional, Bavbek, N., additional, Cook, T., additional, Alpers, C., additional, Berthoux, F., additional, Bonsib, S., additional, D’Agati, V., additional, D’Amico, G., additional, Emancipator, S., additional, Emmal, F., additional, Fervenza, F., additional, Florquin, S., additional, Fogo, A., additional, Groene, H., additional, Haas, M., additional, Hill, P., additional, Hogg, R., additional, Hsu, S., additional, Hunley, T., additional, Hladunewich, M., additional, Jennette, C., additional, Joh, K., additional, Julian, B., additional, Kawamura, T., additional, Lai, F., additional, Leung, C., additional, Li, L., additional, Li, P., additional, Liu, Z., additional, Massat, A., additional, Mackinnon, B., additional, Mezzano, S., additional, Schena, F., additional, Tomino, Y., additional, Walker, P., additional, Wang, H., additional, Weening, J., additional, Yoshikawa, N., additional, Zeng, C.-H., additional, Shi, S., additional, Nogi, C., additional, Suzuki, H., additional, Koike, K., additional, Hirano, K., additional, Yokoo, T., additional, Hanai, M., additional, Fukami, K., additional, Takahashi, K., additional, Yuzawa, Y., additional, Niwa, M., additional, Yasuda, Y., additional, Maruyama, S., additional, Ichikawa, D., additional, Suzuki, T., additional, Shirai, S., additional, Fukuda, A., additional, Fujimoto, S., additional, and Trimarchi, H., additional
- Published
- 2022
- Full Text
- View/download PDF
26. On the use of crystal vibrational modes in the estimation of the anisotropic displacement parameters of hydrogen atoms in molecular crystals: para-Nitroaniline as a test case
- Author
-
Pozzi, C. Gustavo, Fantoni, Adolfo C., Goeta, Andrés E., de Matos Gomes, Etelvina, McIntyre, Garry J., and Punte, Graciela
- Published
- 2013
- Full Text
- View/download PDF
27. Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth
- Author
-
Zagato, E, Pozzi, C, Bertocchi, A, Schioppa, T, Saccheri, F, Guglietta, S, Fosso, B, Melocchi, L, Nizzoli, G, Troisi, J, Marzano, M, Oresta, B, Spadoni, I, Atarashi, K, Carloni, S, Arioli, S, Fornasa, G, Asnicar, F, Segata, N, Guglielmetti, S, Honda, K, Pesole, G, Vermi, W, Penna, G, Rescigno, M, Zagato E., Pozzi C., Bertocchi A., Schioppa T., Saccheri F., Guglietta S., Fosso B., Melocchi L., Nizzoli G., Troisi J., Marzano M., Oresta B., Spadoni I., Atarashi K., Carloni S., Arioli S., Fornasa G., Asnicar F., Segata N., Guglielmetti S., Honda K., Pesole G., Vermi W., Penna G., Rescigno M., Zagato, E, Pozzi, C, Bertocchi, A, Schioppa, T, Saccheri, F, Guglietta, S, Fosso, B, Melocchi, L, Nizzoli, G, Troisi, J, Marzano, M, Oresta, B, Spadoni, I, Atarashi, K, Carloni, S, Arioli, S, Fornasa, G, Asnicar, F, Segata, N, Guglielmetti, S, Honda, K, Pesole, G, Vermi, W, Penna, G, Rescigno, M, Zagato E., Pozzi C., Bertocchi A., Schioppa T., Saccheri F., Guglietta S., Fosso B., Melocchi L., Nizzoli G., Troisi J., Marzano M., Oresta B., Spadoni I., Atarashi K., Carloni S., Arioli S., Fornasa G., Asnicar F., Segata N., Guglielmetti S., Honda K., Pesole G., Vermi W., Penna G., and Rescigno M.
- Abstract
The microbiota has been shown to promote intestinal tumourigenesis, but a possible anti-tumourigenic effect has also been postulated. Here, we demonstrate that changes in the microbiota and mucus composition are concomitant with tumourigenesis. We identified two anti-tumourigenic strains of the microbiota—Faecalibaculum rodentium and its human homologue, Holdemanella biformis—that are strongly under-represented during tumourigenesis. Reconstitution of ApcMin/+ or azoxymethane- and dextran sulfate sodium-treated mice with an isolate of F. rodentium (F. PB1) or its metabolic products reduced tumour growth. Both F. PB1 and H. biformis produced short-chain fatty acids that contributed to control protein acetylation and tumour cell proliferation by inhibiting calcineurin and NFATc3 activation in mouse and human settings. We have thus identified endogenous anti-tumourigenic bacterial strains with strong diagnostic, therapeutic and translational potential.
- Published
- 2020
28. Activity-based occupational therapy intervention for delirium superimposed on dementia in nursing home setting: a feasibility study
- Author
-
Pozzi, C, Lanzoni, A, Lucchi, E, Salimbeni, I, Devreese, L, Bellelli, G, Fabbo, A, Morandi, A, Pozzi C., Lanzoni A., Lucchi E., Salimbeni I., DeVreese L. P., Bellelli G., Fabbo A., Morandi A., Pozzi, C, Lanzoni, A, Lucchi, E, Salimbeni, I, Devreese, L, Bellelli, G, Fabbo, A, Morandi, A, Pozzi C., Lanzoni A., Lucchi E., Salimbeni I., DeVreese L. P., Bellelli G., Fabbo A., and Morandi A.
- Abstract
Objective: Multi-component interventions can reduce delirium incidence. Occupational therapy (OT) has been effective in the management of dementia. We designed a real-world feasibility study of an OT intervention in the management of delirium superimposed on dementia (DSD). Methods: We included a convenient sample of 22 patients older than 65 years of age with delirium and moderate dementia admitted to a nursing home (NH). The OT procedures were standardized according to the level of agitation or sedation of the patient and based on a structured OT evaluation. The Canadian Occupational Performance Measure (COPM) was used to evaluate the proxy perception of performance in the daily activities at baseline and at delirium resolution. Results: The mean age was 86.45 ± 6.46 years. The first daily treatment was delivered in the entire sample, while the second was delivered in 63.46% on day 1, 72.72% on day 2, 25% on day 3, 66.67% on day 4, 100% on days 5 and 6. The main time of the first daily treatment varied, day 1 through day 6, from 14.8 ± 8.5 to 20 ± 0 min; while the second daily treatment, in the same period, from 3.9 ± 6.7 to 20.1 ± 0 min. The mean time of the first treatment varied day 1 through day 6 from 14.8 ± 8.5 to 20 ± 0 min, while the second treatment from 3.9 ± 6.7 to 20.1 ± 0 min. The COPM proxy performance and proxy satisfaction increased from delirium onset to delirium resolution. Conclusions: This is the first study to report the feasibility of an OT intervention for the management of DSD in a NH setting. The results are important to support future trials on delirium management in a setting often understudied and underrepresented.
- Published
- 2020
29. The applicability and feasibility of occupational therapy in delirium care
- Author
-
Pozzi, C, Tatzer, V, Alvarez, E, Lanzoni, A, Graff, M, Pozzi C., Tatzer V. C., Alvarez E. A., Lanzoni A., Graff M. J. L., Pozzi, C, Tatzer, V, Alvarez, E, Lanzoni, A, Graff, M, Pozzi C., Tatzer V. C., Alvarez E. A., Lanzoni A., and Graff M. J. L.
- Abstract
Purpose: To perform a narrative review of studies on the applicability and feasibility of occupational therapy in persons with delirium by analyzing evaluation and procedural methods in the therapeutic settings. Methods: Starting from the international classification of disability, the focus was to understand if and how occupational therapy as a multi-component intervention can reduce the duration and intensity of delirium to prevent future disabilities. This review also includes scientific studies demonstrating the benefits of occupational therapy in terms of increased functional and occupational outcomes. Finally, the evaluation modalities and the therapeutic procedures performed by the occupational therapist have been analyzed. Results: The non-pharmacological treatments occupational therapists perform in people with delirium in intensive care settings are supported by scientific evidence. Conclusions: There is preliminary evidence of the benefit of including occupational therapy in early stages of rehabilitation in acute care to prevent and treat delirium. Nevertheless, further studies are necessary to define the different aspects of the multidisciplinary approach that is common in geriatric practice, primarily determining the adequate timing, and intensity of interventions as well as its appropriate settings.
- Published
- 2020
30. The present and the future of occupational therapy
- Author
-
Pozzi, C, Lanzoni, A, Graff, MJL, Morandi, A, Cavalli, S, Leorin, C, Cauli, O, Pozzi C., Cavalli S., Leorin C., Cauli O., Morandi A., Pozzi, C, Lanzoni, A, Graff, MJL, Morandi, A, Cavalli, S, Leorin, C, Cauli, O, Pozzi C., Cavalli S., Leorin C., Cauli O., and Morandi A.
- Abstract
The present and the future are often interacting in the care of older people. The cultural changes in Europe require the occupational therapy to focus on a personalized approach given the ageing population in different cultures. In this matter, loneliness and boredom are two emerging conditions, which require a specific approach to improve the quality of life of the elderly in different settings. Technology and assistive technology might represent a venue to improve the occupational therapy management of older people. Finally, the continuous evaluation of occupational therapy interventions in clinical trials is key to provide the scientific evidence for the best approach to elderly people.
- Published
- 2020
31. Morphological aspects in light chain deposition disease
- Author
-
Ferrario, F., Curioni, S., Arrigo, G., Pozzi, C., Banfi, G., Touchard, Guy, editor, Aucouturier, Pierre, editor, Hermine, Olivier, editor, and Ronco, Pierre, editor
- Published
- 2003
- Full Text
- View/download PDF
32. Occupational Therapists care and COVID-19 Pandemic: An Observational Survey in Europe.
- Author
-
Pozzi, C., Lanzoni, A., Battain, P., Alvarez, E., Tobar, E, Hersche, R, Cavalli, S., Monsò, A., Llarch, E., Bellelli, G., Morandi, A., Graff, M.J.L., Pozzi, C., Lanzoni, A., Battain, P., Alvarez, E., Tobar, E, Hersche, R, Cavalli, S., Monsò, A., Llarch, E., Bellelli, G., Morandi, A., and Graff, M.J.L.
- Abstract
Item does not contain fulltext
- Published
- 2022
33. Occupational Therapists and COVID-19 Pandemic: An Observational Survey in Europe
- Author
-
Pozzi, C., Lanzoni, A., Battain, P.C., Alvarez, E., Tobar, E, Hersche, R, Cavalli, S., Monso, A., Llarch, E., Bellelli, G., Morandi, A., Graff, M.J., Pozzi, C., Lanzoni, A., Battain, P.C., Alvarez, E., Tobar, E, Hersche, R, Cavalli, S., Monso, A., Llarch, E., Bellelli, G., Morandi, A., and Graff, M.J.
- Abstract
Item does not contain fulltext
- Published
- 2022
34. Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in complex with compound 28 (JMV-7038)
- Author
-
Tassone, G., primary, Benvenuti, M., additional, Verdirosa, F., additional, Corsica, G., additional, Chelini, G., additional, De Luca, F., additional, Docquier, J.D., additional, Pozzi, C., additional, and Mangani, S., additional
- Published
- 2022
- Full Text
- View/download PDF
35. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update
- Author
-
Coppo, R., D'Arrigo, G., Tripepi, G., Russo, M. L., Roberts, I. S. D., Bellur, S., Cattran, D., Cook, T. H., Feehally, J., Tesar, V., Maixnerova, D., Peruzzi, L., Amore, A., Lundberg, S., Di Palma, A. M., Gesualdo, L., Emma, F., Rollino, C., Praga, M., Biancone, L., Pani, A., Feriozzi, S., Polci, R., Barratt, J., Del Vecchio, L., Locatelli, F., Pierucci, A., Caliskan, Y., Perkowska-Ptasinska, A., Durlik, M., Moggia, E., Ballarin, J. C., Wetzels, J. F. M., Goumenos, D., Papasotiriou, M., Galesic, K., Toric, L., Papagianni, A., Stangou, M., Benozzi, L., Cusinato, S., Berg, U., Topaloglu, R., Maggio, M., Ots-Rosenberg, M., D'Amico, M., Geddes, C., Balafa, O., Quaglia, M., Cravero, R., Cirami, C. L., Fellstrom, B., Floege, J., Egido, J., Mallamaci, F., Zoccali, C., Fuiano, L., Beltrame, G., Camilla, R., Segoloni, G., Colla, L., Angioi, A., Piras, L., Cancarini, G., Ravera, S., Ballarin, J., Di Giulio, S., Pugliese, F., Serriello, I., Sever, M., Kilicaslan, I., Peters, H., Carvalho, F., Da Costa Ferreira, A. C., Wiecek, A., Magistroni, R., Bilginer, Y., Giacchino, F., Papastirou, M., Siamopoulos, K., Galliani, M., Stratta, P., Bergia, R., Salvadori, M., Cirami, L., Kloster Smerud, H., Ferrario, F., Stellato, T., Martin, C., Eitner, F., Rauen, T., Lupo, A., Bernich, P., Mene, P., Morosetti, M., Van Kooten, C., Rabelink, T., Reinders, M. E. J., Boria Grinyo, J. M., Savoldi, S., Licata, C., Mizerska-Wasiak, M., Roszkowska-Blaim, M., Martina, G., Messuerotti, A., Dal Canton, A., Esposito, C., Migotto, C., Triolo, G., Mariano, F., Pozzi, C., Boero, R., Mazzucco, G., Giannakakis, C., Honsova, E., Sundelin, B., Gutierrez, E., Asunis, A. M., Tardanico, R., Arce Terroba, J., Fortunato, M., Pantzaki, A., Ozluk, Y., Steenbergen, E., Soderberg, M., Riispere, Z., Furci, L., Orhan, D., Kipgen, D., Casartelli, D., Galesic Ljubanovic, D., Akiopoulou, H., Bertoni, E., Cannata Ortiz, P., Karkoszka, H., Groene, H. J., Stoppacciaro, A., Bajema, I., Bruijn, J., Fulladosa Oliveras, X., Maldyk, J., Ioachim, E., and Internal Medicine
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Adolescent ,030232 urology & nephrology ,Renal function ,030204 cardiovascular system & hematology ,Kidney ,Nephropathy ,Cohort Studies ,03 medical and health sciences ,Glomerulonephritis ,0302 clinical medicine ,renal biopsy ,Interquartile range ,IgA nephropathy ,progression ,risk factors ,Child ,Disease Progression ,Female ,Follow-Up Studies ,Glomerular Filtration Rate ,Glomerulonephritis, IGA ,Humans ,Prognosis ,Medicine ,Endocapillary hypercellularity ,IGA ,Transplantation ,medicine.diagnostic_test ,business.industry ,medicine.disease ,medicine.anatomical_structure ,Renal pathology ,Nephrology ,Cohort ,Renal biopsy ,Renal disorders Radboud Institute for Health Sciences [Radboudumc 11] ,business - Abstract
Background It is unknown whether renal pathology lesions in immunoglobulin A nephropathy (IgAN) correlate with renal outcomes over decades of follow-up. Methods In 1130 patients of the original Validation Study of the Oxford Classification for IgA Nephropathy (VALIGA) cohort, we studied the relationship between the MEST score (mesangial hypercellularity, M; endocapillary hypercellularity, E; segmental glomerulosclerosis, S; tubular atrophy/interstitial fibrosis, T), crescents (C) and other histological lesions with both a combined renal endpoint [50% estimated glomerular filtration rate (eGFR) loss or kidney failure] and the rate of eGFR decline over a follow-up period extending to 35 years [median 7 years (interquartile range 4.1–10.8)]. Results In this extended analysis, M1, S1 and T1–T2 lesions as well as the whole MEST score were independently related with the combined endpoint (P Conclusion Long-term follow-up analyses of the VALIGA cohort showed that the independent relationship between kidney biopsy findings and the risk of progression towards kidney failure in IgAN remains unchanged across all age groups and decades after the renal biopsy.
- Published
- 2020
36. Targeting the dimer-monomer equilibrium of thymidylate synthase, to accelerate protein degradation and cancer cell growth inhibition
- Author
-
Costi, Maria Paola, Venturelli, A, Ponterini, G, Pozzi, C, Wade, Rebecca, Giovannetti, E, Rimessi, A, Tagliazucchi, L, Moschella, M, Marverti, G, and D’Arca, D
- Published
- 2022
37. Toward sustainable aviation industry: assessing the impact of emissions from aircraft trajectories
- Author
-
A. Riccio, D. Di Luccio, E. Bucchignani, Barbero, D., Calori, G, Finardi, S, Nanni, A, Pepe, N, Pozzi, C, Radice, P, Silibello, C., Tinarelli, G, M. Ciaburri, G. Duca, and Russo, R.
- Abstract
Aviation is known as one of the industries that contribute to climate change and the most relevant contributor with reference to emissions at high altitude. Aviation industry’s GHGs (Greenhouse Gases) are set to continue to grow, despite technological innovation advancement in this sector, and the aviation industry is highly unlikely to achieve the carbon neutral growth within the next years and it will likely remain an important source of air pollutants. Since 1990, NOx (Nitrogen Oxides) emissions from aviation have doubled and its share has quadrupled (while emissions from other sectors like traffic or industry have been significantly reduced); in the same way, relative contribution of sulphur oxides and carbon monoxide have gone up. In 2015, it accounted for 14% of all EU transport NOx emissions and for 7% of the total EU NOx emissions. In the effort to mitigate the effects of greenhouse gases and air pollution, a lot of improvement is needed to ensure that the aviation industry reduces its carbon footprint and impact on air pollution in this fast-growing economic scenario. For these reasons, an in-depth study of the relationship between environment and aviation, focusing on all aspects of ATM (Air Traffic Management), is needed to reduce the environmental impact of flight operations. For this purpose, an advanced system for studying the impact of air quality at different spatial and temporal scales is proposed to analyze in detail the impact of emissions from the aeronautical sector, both on a local scale, e.g. in TMAs (Terminal Maneuvering Areas), and on a regional/global scale, e.g. along cruise routes beyond the planetary boundary layer and into the stratosphere. In this work, we present a complete system to assess the impact of emissions from the aviation sector, follow their fate in the atmosphere due to dispersion processes, evaluate the production of secondary pollutants (mainly ozone and particulate matter) and evaluate the effects of climatological interest (radiative effects, transport in the stratosphere). For demonstration purposes, it will be shown how these tools can be used for a detailed bottom-up analysis of airport emissions on the local scale; global emissions will be used for an analysis of the effects of the trend of emissions from the aeronautical sector.
- Published
- 2021
- Full Text
- View/download PDF
38. Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases
- Author
-
Santucci, M., Luciani, R., Gianquinto, E., Pozzi, C., Di Pisa, F., Dello Iacono, L., Landi, G., Tagliazucchi, L., Mangani, S., Spyrakis, F., and Costi, M. P.
- Subjects
trypanosomiasis ,Drug discovery ,DHFR-TS ,GSK Kinetobox ,Leishmaniasis ,Medium throughput screening ,Molecular modelling ,PTR1 ,Trypanosomiasis ,Article ,molecular modelling ,drug discovery ,RS1-441 ,Pharmacy and materia medica ,parasitic diseases ,Medicine ,medium throughput screening - Abstract
Three open-source anti-kinetoplastid chemical boxes derived from a whole-cell phenotypic screening by GlaxoSmithKline (Tres Cantos Anti-Kinetoplastid Screening, TCAKS) were exploited for the discovery of a novel core structure inspiring new treatments of parasitic diseases targeting the trypansosmatidic pteridine reductase 1 (PTR1) and dihydrofolate reductase (DHFR) enzymes. In total, 592 compounds were tested through medium-throughput screening assays. A subset of 14 compounds successfully inhibited the enzyme activity in the low micromolar range of at least one of the enzymes from both Trypanosoma brucei and Lesihmania major parasites (pan-inhibitors), or from both PTR1 and DHFR-TS of the same parasite (dual inhibitors). Molecular docking studies of the protein–ligand interaction focused on new scaffolds not reproducing the well-known antifolate core clearly explaining the experimental data. TCMDC-143249, classified as a benzenesulfonamide derivative by the QikProp descriptor tool, showed selective inhibition of PTR1 and growth inhibition of the kinetoplastid parasites in the 5 μM range. In our work, we enlarged the biological profile of the GSK Kinetobox and identified new core structures inhibiting selectively PTR1, effective against the kinetoplastid infectious protozoans. In perspective, we foresee the development of selective PTR1 and DHFR inhibitors for studies of drug combinations.
- Published
- 2021
39. B22 - Radium-223 in metastatic castration-resistant prostate cancer (mCRPC): efficacy and safety in real-life experience
- Author
-
Rebuzzi, S.E., Prelaj, A., Pozzi, C., Ferrara, C., Frantellizzi, V., Follacchio, G.A., de Vincentis, G., Tomao, S., and Bianco, V.
- Published
- 2017
- Full Text
- View/download PDF
40. An interdisciplinary statement of scientific societies for the advancement of delirium care across Europe (EDA, EANS, EUGMS, COTEC, IPTOP/WCPT)
- Author
-
Morandi, A, Pozzi, C, Milisen, K, Hobbelen, H, Bottomley, J, Lanzoni, A, Tatzer, V, Carpena, M, Cherubini, A, Ranhoff, A, Maclullich, A, Teodorczuk, A, Bellelli, G, Morandi A., Pozzi C., Milisen K., Hobbelen H., Bottomley J. M., Lanzoni A., Tatzer V. C., Carpena M. G., Cherubini A., Ranhoff A., MacLullich A. M. J., Teodorczuk A., Bellelli G., Morandi, A, Pozzi, C, Milisen, K, Hobbelen, H, Bottomley, J, Lanzoni, A, Tatzer, V, Carpena, M, Cherubini, A, Ranhoff, A, Maclullich, A, Teodorczuk, A, Bellelli, G, Morandi A., Pozzi C., Milisen K., Hobbelen H., Bottomley J. M., Lanzoni A., Tatzer V. C., Carpena M. G., Cherubini A., Ranhoff A., MacLullich A. M. J., Teodorczuk A., and Bellelli G.
- Abstract
Background: Delirium is a geriatric syndrome that presents in 1 out of 5 hospitalized older patients. It is also common in the community, in hospices, and in nursing homes. Delirium prevalence varies according to clinical setting, with rates of under 5% in minor elective surgery but up to 80% in intensive care unit patients. Delirium has severe adverse consequences, but despite this and its high prevalence, it remains undetected in the majority of cases. Optimal delirium care requires an interdisciplinary, multi-dimensional diagnostic and therapeutic approach involving doctors, nurses, physiotherapists, and occupational therapists. However, there are still important gaps in the knowledge and management of this syndrome. Main body: The objective of this paper is to promote the interdisciplinary approach in the prevention and management of delirium as endorsed by a delirium society (European Delirium Association, EDA), a geriatrics society (European Geriatric Medicine Society, EuGMS), a nursing society (European Academy of Nursing Science, EANS), an occupational therapy society (Council of Occupational Therapists for European Countries, COTEC), and a physiotherapy society (International Association of Physical Therapists working with Older People of the World Confederation for Physical Therapy, IPTOP/WCPT). Short conclusion: In this paper we have strongly promoted and supported interdisciplinary collaboration underlying the necessity of increasing communication among scientific societies. We have also provided suggestions on how to fill the current gaps via improvements in undergraduate and postgraduate delirium education among European Countries.
- Published
- 2019
41. Decostruire e costruire: il ruolo dell'antropologia nell'analisi dell'interazione tra biomedicina e medicina cinese
- Author
-
Pozzi, C, Pozzi C., Pozzi, C, and Pozzi C.
- Abstract
A causa della crescente diffusione della medicina cinese in Italia, il Sistema Sanitario Nazionale si è ritrovato a negoziare i suoi confini con una variegata offerta di terapie provenienti dalla Cina. In questo articolo, facendo riferimento ad una ricerca etnografica condotta nella città di Milano e che ha come protagonisti medici e terapeuti, illustro come l’indagine antropologica possa contribuire all’apertura di un dialogo tra biomedicina e medicina cinese. Per permettere ciò, l’antropologo deve prima passare attraverso una fase di decostruzione, ovvero mettere in discussione i fondamenti teorici, storici e culturali di questi due sistemi medici, per poi costruire un’analisi dell’interazione tra biomedicina e medicina cinese, cogliendo l’importanza di pratiche, attori e luoghi che concorrono quotidianamente a dare vita a questo rapporto.
- Published
- 2019
42. The Diagnosis and Management of AIDS Patients with Mycotic Infections
- Author
-
Viviani, M. A., Tortorano, A. M., Grancini, A., Malaspina, C., Alessio, M. G., Pozzi, C., Vaheri, Antti, editor, Tilton, Richard C., editor, and Balows, Albert, editor
- Published
- 1991
- Full Text
- View/download PDF
43. Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in Complex with compound 14 (JMV-6931)
- Author
-
Tassone, G., primary, Benvenuti, M., additional, Verdirosa, F., additional, Sannio, F., additional, Marcoccia, F., additional, Docquier, J.D., additional, Pozzi, C., additional, and Mangani, S., additional
- Published
- 2021
- Full Text
- View/download PDF
44. Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in Complex with compound 10 (JMV-7210)
- Author
-
Tassone, G., primary, Benvenuti, M., additional, Verdirosa, F., additional, Sannio, F., additional, Mangani, S., additional, Docquier, J.D., additional, Pozzi, C., additional, and Marcoccia, F., additional
- Published
- 2021
- Full Text
- View/download PDF
45. Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in Complex with compound 8 (JMV-7207)
- Author
-
Tassone, G., primary, Benvenuti, M., additional, Verdirosa, F., additional, Sannio, F., additional, Marcoccia, F., additional, Docquier, J.D., additional, Pozzi, C., additional, and Mangani, S., additional
- Published
- 2021
- Full Text
- View/download PDF
46. Crystal structure of human mitochondrial ferritin (hMTF) Fe(II)-loaded for 120 minutes showing either a dioxygen or a superoxide anion coordinated to iron ions in the ferroxidase site.
- Author
-
Pozzi, C., primary, Ciambellotti, S., additional, Tassone, G., additional, Turano, P., additional, and Mangani, S., additional
- Published
- 2021
- Full Text
- View/download PDF
47. Crystal structure of human mitochondrial ferritin (hMTF) Fe(II)-loaded for 5 minutes showing a peroxide anion as bridging species of iron ions in the ferroxidase site
- Author
-
Pozzi, C., primary, Ciambellotti, S., additional, Tassone, G., additional, Turano, P., additional, and Mangani, S., additional
- Published
- 2021
- Full Text
- View/download PDF
48. Crystal structure of human mitochondrial ferritin (hMTF) Fe(II)-loaded for 3 minutes showing a peroxide anion as bridging species of iron ions in the ferroxidase site
- Author
-
Pozzi, C., primary, Ciambellotti, S., additional, Tassone, G., additional, Turano, P., additional, and Mangani, S., additional
- Published
- 2021
- Full Text
- View/download PDF
49. Crystal structure of OXA-10loop48 in complex with hydrolyzed meropenem
- Author
-
Tassone, G., primary, Di Pisa, F., additional, Benvenuti, M., additional, De Luca, F., additional, Pozzi, C., additional, Mangani, S., additional, and Docquier, J.D., additional
- Published
- 2021
- Full Text
- View/download PDF
50. Crystal Structure of the OXA-48 Carbapenem-Hydrolyzing Class D beta-Lactamase in Complex with the DBO inhibitor ANT3310
- Author
-
Docquier, J.D., primary, Pozzi, C., additional, De Luca, F., additional, Benvenuti, M., additional, and Mangani, S., additional
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.